21 results
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
of our product candidates for any or all targeted indications.
Drug-related side effects could affect patient recruitment, the ability of enrolled
6-K
SPRC
SciSparc Ltd
29 Jan 24
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
4:00pm
On January 29, 2024, SciSparc Ltd. (the “Company”) issued a press release titled “SciSparc Announces Initiation of Patient Recruitment for its … .
EXHIBIT INDEX
Exhibit No.
Press release issued by SciSparc Ltd., titled “SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial
6-K
EX-99.1
SPRC
SciSparc Ltd
29 Jan 24
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
4:00pm
Exhibit 99.1
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder … the initiation of patient recruitment for its clinical trial in children suffering from autism spectrum disorder (“ASD”) at Soroka Medical Center in Israel
6-K
EX-99.1
ksozve9 f7gcae1xxvz9
2 Aug 22
SciSparc Signs Clinical Trial Agreement with Yale University to Conduct its Phase IIb Trial in Tourette Syndrome
4:00pm
6-K
EX-99.1
4tou3d8hj shpumb
6 Jan 22
SciSparc Announces Recruitment of First Patient for its Phase IIa Clinical Trial in Alzheimer’s Disease
9:09am
6-K
kq4toa2a1q
6 Jan 22
SciSparc Announces Recruitment of First Patient for its Phase IIa Clinical Trial in Alzheimer’s Disease
9:09am
424B4
6tlwdtdw
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
18a ag8fvh7b42tzn
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
kl8l48k466 7by4
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
z9c 3rf4luw4ezbf
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
x99 4kngo
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
6-K
EX-99.1
hv0 4yaljgg
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm